# FDA recall D-1457-2016

> **Actavis Inc** · Class II · drug recall initiated 2016-06-30.

## Product

Glipizide 2.5 mg Extended-release tablets, 30-count bottle, Rx Only, Manufactured By: Patheon Pharmaceuticals Inc Cincinnati, OH  45237, NDC 00591-0900-30

## Reason for recall

Failed Dissolution Specifications: Glipizide 2.5 mg ER  Tablets exceeded  dissolution specification rates for the 10 hour testing point.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-1457-2016
- **Recalling firm:** Actavis Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2016-06-30
- **Report date:** 2016-08-24
- **Termination date:** 2017-07-03

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Parsippany, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1457-2016

## Citation

> AI Analytics. FDA recall D-1457-2016. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-1457-2016. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*